https://stock.noler.com/us/stock/cellcyte-genetics-corp https://stock.noler.com/us/stock/cellcyte-genetics-corp/accounts-payable https://stock.noler.com/us/stock/cellcyte-genetics-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/accounts-payable-other-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/accrued-liabilities-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/cellcyte-genetics-corp/accumulated-depreciation https://stock.noler.com/us/stock/cellcyte-genetics-corp/accumulated-depreciation-change https://stock.noler.com/us/stock/cellcyte-genetics-corp/accumulated-depreciation-depletion-and-amortization-expense-property-plant-and-equipment-current-charge https://stock.noler.com/us/stock/cellcyte-genetics-corp/accumulated-depreciation-depletion-and-amortization-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/cellcyte-genetics-corp/acquired-finite-lived-intangible-asset-residual-value https://stock.noler.com/us/stock/cellcyte-genetics-corp/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/cellcyte-genetics-corp/additional-paid-in-capital https://stock.noler.com/us/stock/cellcyte-genetics-corp/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/cellcyte-genetics-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/cellcyte-genetics-corp/allowance-for-loan-and-lease-losses-write-offs https://stock.noler.com/us/stock/cellcyte-genetics-corp/amortization https://stock.noler.com/us/stock/cellcyte-genetics-corp/amortization-of-financing-costs https://stock.noler.com/us/stock/cellcyte-genetics-corp/asset-impairment-charges https://stock.noler.com/us/stock/cellcyte-genetics-corp/cash-acquired-from-acquisition https://stock.noler.com/us/stock/cellcyte-genetics-corp/cash-and-equivalents https://stock.noler.com/us/stock/cellcyte-genetics-corp/cash-change https://stock.noler.com/us/stock/cellcyte-genetics-corp/cash-flow-breakdown https://stock.noler.com/us/stock/cellcyte-genetics-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cellcyte-genetics-corp/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/cellcyte-genetics-corp/common-stockholders-equity https://stock.noler.com/us/stock/cellcyte-genetics-corp/comprehensive-income https://stock.noler.com/us/stock/cellcyte-genetics-corp/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/cellcyte-genetics-corp/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/cellcyte-genetics-corp/convertible-long-term-notes-payable https://stock.noler.com/us/stock/cellcyte-genetics-corp/convertible-notes-payable https://stock.noler.com/us/stock/cellcyte-genetics-corp/convertible-notes-payable-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/cellcyte-genetics-corp/current-assets https://stock.noler.com/us/stock/cellcyte-genetics-corp/current-liabilities https://stock.noler.com/us/stock/cellcyte-genetics-corp/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/cellcyte-genetics-corp/debt-conversion-converted-instrument-amount-1 https://stock.noler.com/us/stock/cellcyte-genetics-corp/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/cellcyte-genetics-corp/debt-increase-accrued-interest https://stock.noler.com/us/stock/cellcyte-genetics-corp/debt-increase-decrease-other-net https://stock.noler.com/us/stock/cellcyte-genetics-corp/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/cellcyte-genetics-corp/deferred-discounts-finance-charges-and-interest-included-in-receivables https://stock.noler.com/us/stock/cellcyte-genetics-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/cellcyte-genetics-corp/diluted-shares https://stock.noler.com/us/stock/cellcyte-genetics-corp/dividends-share-based-compensation-stock https://stock.noler.com/us/stock/cellcyte-genetics-corp/due-to-related-parties https://stock.noler.com/us/stock/cellcyte-genetics-corp/due-to-related-parties-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/cellcyte-genetics-corp/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/cellcyte-genetics-corp/eps https://stock.noler.com/us/stock/cellcyte-genetics-corp/eps-basic https://stock.noler.com/us/stock/cellcyte-genetics-corp/extinguishment-of-debt-gain-loss-income-tax https://stock.noler.com/us/stock/cellcyte-genetics-corp/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/cellcyte-genetics-corp/financing-cash-flow https://stock.noler.com/us/stock/cellcyte-genetics-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/cellcyte-genetics-corp/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/cellcyte-genetics-corp/finite-lived-patents-gross https://stock.noler.com/us/stock/cellcyte-genetics-corp/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/cellcyte-genetics-corp/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/cellcyte-genetics-corp/general-and-administrative-expense https://stock.noler.com/us/stock/cellcyte-genetics-corp/general-insurance-expense https://stock.noler.com/us/stock/cellcyte-genetics-corp/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/cellcyte-genetics-corp/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/cellcyte-genetics-corp/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/cellcyte-genetics-corp/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/cellcyte-genetics-corp/impairment-of-real-estate https://stock.noler.com/us/stock/cellcyte-genetics-corp/income-loss-from https://stock.noler.com/us/stock/cellcyte-genetics-corp/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/cellcyte-genetics-corp/income-loss-from-per-basic-share https://stock.noler.com/us/stock/cellcyte-genetics-corp/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/cellcyte-genetics-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/cellcyte-genetics-corp/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/cellcyte-genetics-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/cellcyte-genetics-corp/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/cellcyte-genetics-corp/increase-decrease-in-intangible-assets-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/increase-decrease-in-other-accounts-payable https://stock.noler.com/us/stock/cellcyte-genetics-corp/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/cellcyte-genetics-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/cellcyte-genetics-corp/insurance-commissions https://stock.noler.com/us/stock/cellcyte-genetics-corp/interest-and-dividend-income-operating https://stock.noler.com/us/stock/cellcyte-genetics-corp/interest-costs-incurred https://stock.noler.com/us/stock/cellcyte-genetics-corp/interest-paid https://stock.noler.com/us/stock/cellcyte-genetics-corp/interest-paid-capitalized https://stock.noler.com/us/stock/cellcyte-genetics-corp/investing-cash-flow https://stock.noler.com/us/stock/cellcyte-genetics-corp/investment-income-interest https://stock.noler.com/us/stock/cellcyte-genetics-corp/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/cellcyte-genetics-corp/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/cellcyte-genetics-corp/legal-fees https://stock.noler.com/us/stock/cellcyte-genetics-corp/liabilities-noncurrent https://stock.noler.com/us/stock/cellcyte-genetics-corp/net-change-in-cash https://stock.noler.com/us/stock/cellcyte-genetics-corp/net-income https://stock.noler.com/us/stock/cellcyte-genetics-corp/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/cellcyte-genetics-corp/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/cellcyte-genetics-corp/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/cellcyte-genetics-corp/noncash-contribution-expense https://stock.noler.com/us/stock/cellcyte-genetics-corp/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/cellcyte-genetics-corp/noncash-or-part-noncash-acquisition-intangible-assets-acquired-1 https://stock.noler.com/us/stock/cellcyte-genetics-corp/notes-and-loans-payable-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/notes-payable-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/cellcyte-genetics-corp/operating-cash-flow https://stock.noler.com/us/stock/cellcyte-genetics-corp/operating-costs-and-expenses https://stock.noler.com/us/stock/cellcyte-genetics-corp/operating-expenses https://stock.noler.com/us/stock/cellcyte-genetics-corp/other-assets https://stock.noler.com/us/stock/cellcyte-genetics-corp/other-expenses https://stock.noler.com/us/stock/cellcyte-genetics-corp/other-general-and-administrative-expense https://stock.noler.com/us/stock/cellcyte-genetics-corp/other-long-term-debt-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/other-noncash-expense https://stock.noler.com/us/stock/cellcyte-genetics-corp/other-noncash-income-expense https://stock.noler.com/us/stock/cellcyte-genetics-corp/other-operating-income-expense-net https://stock.noler.com/us/stock/cellcyte-genetics-corp/other-receivables https://stock.noler.com/us/stock/cellcyte-genetics-corp/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/cellcyte-genetics-corp/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/cellcyte-genetics-corp/payments-for-proceeds-from-derivative-instrument-financing-activities https://stock.noler.com/us/stock/cellcyte-genetics-corp/payments-for-tenant-improvements https://stock.noler.com/us/stock/cellcyte-genetics-corp/payments-to-acquire-other-property-plant-and-equipment https://stock.noler.com/us/stock/cellcyte-genetics-corp/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/cellcyte-genetics-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/cellcyte-genetics-corp/pretax-income https://stock.noler.com/us/stock/cellcyte-genetics-corp/pretax-income-domestic https://stock.noler.com/us/stock/cellcyte-genetics-corp/pro-forma-weighted-average-shares-outstanding-diluted https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-contributed-capital https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-convertible-debt https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-issuance-of-medium-term-notes https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-related-party-debt https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/cellcyte-genetics-corp/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/cellcyte-genetics-corp/professional-and-contract-services-expense https://stock.noler.com/us/stock/cellcyte-genetics-corp/professional-fees https://stock.noler.com/us/stock/cellcyte-genetics-corp/profit-loss https://stock.noler.com/us/stock/cellcyte-genetics-corp/property-plant-and-equipment-additions https://stock.noler.com/us/stock/cellcyte-genetics-corp/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/cellcyte-genetics-corp/property-plant-and-equipment-gross-change https://stock.noler.com/us/stock/cellcyte-genetics-corp/property-plant-and-equipment-other-accumulated-depreciation https://stock.noler.com/us/stock/cellcyte-genetics-corp/property-plant-and-equipment-other-net https://stock.noler.com/us/stock/cellcyte-genetics-corp/property-plant-and-equipment-owned-net https://stock.noler.com/us/stock/cellcyte-genetics-corp/property-plant-equipment https://stock.noler.com/us/stock/cellcyte-genetics-corp/public-float https://stock.noler.com/us/stock/cellcyte-genetics-corp/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/cellcyte-genetics-corp/related-party-transaction-other-revenues-from-transactions-with-related-party https://stock.noler.com/us/stock/cellcyte-genetics-corp/repayments-of-notes-payable https://stock.noler.com/us/stock/cellcyte-genetics-corp/research-and-development https://stock.noler.com/us/stock/cellcyte-genetics-corp/salaries-and-wages https://stock.noler.com/us/stock/cellcyte-genetics-corp/salaries-wages-and-officers-compensation https://stock.noler.com/us/stock/cellcyte-genetics-corp/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-comment-letters-corresp https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-comment-letters-upload https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-filings-10-k https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-filings-10-q https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-filings-10ksb https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-filings-10qsb https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-filings-8-a12g https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-filings-8-k https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-filings-revoked https://stock.noler.com/us/stock/cellcyte-genetics-corp/sec-filings-sb-2 https://stock.noler.com/us/stock/cellcyte-genetics-corp/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/cellcyte-genetics-corp/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/cellcyte-genetics-corp/secondary-offerings-form-effect https://stock.noler.com/us/stock/cellcyte-genetics-corp/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/cellcyte-genetics-corp/share-based-goods-and-nonemployee-services-transaction-cash-flow-effects https://stock.noler.com/us/stock/cellcyte-genetics-corp/shareholders-equity https://stock.noler.com/us/stock/cellcyte-genetics-corp/shares-authorized https://stock.noler.com/us/stock/cellcyte-genetics-corp/shares-issued https://stock.noler.com/us/stock/cellcyte-genetics-corp/stock-based-compensation https://stock.noler.com/us/stock/cellcyte-genetics-corp/stock-compensation-cash-flow-effect-cash-used-to-settle-awards https://stock.noler.com/us/stock/cellcyte-genetics-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/cellcyte-genetics-corp/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/cellcyte-genetics-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/cellcyte-genetics-corp/stock-issued-shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/cellcyte-genetics-corp/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/cellcyte-genetics-corp/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/cellcyte-genetics-corp/tenant-improvements https://stock.noler.com/us/stock/cellcyte-genetics-corp/total-accounts-payable https://stock.noler.com/us/stock/cellcyte-genetics-corp/total-assets https://stock.noler.com/us/stock/cellcyte-genetics-corp/total-liabilities https://stock.noler.com/us/stock/cellcyte-genetics-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/cellcyte-genetics-corp/total-long-term-debt https://stock.noler.com/us/stock/cellcyte-genetics-corp/weighted-average-basic-shares-outstanding-pro-forma https://stock.noler.com/us/stock/cellcyte-genetics-corp/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/cellcyte-genetics-corp/weighted-average-number-of-shares-issued-basic